Document is current

Any future updates will be listed below

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-017-1221-4

Published Online: 2017-01-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark